ADO-TRASTUZUMAB EMTANSINE - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2019-07-31
- Label type
- Indexing - product concept
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 00:18:29
Label at a glance#
ProductADO-TRASTUZUMAB EMTANSINE
Active ingredientADO-TRASTUZUMAB EMTANSINE
Products#
Every source-derived product name is available through these pages.
- ADO-TRASTUZUMAB EMTANSINE
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ADO-TRASTUZUMAB EMTANSINE | SE2KH7T06F | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KADCYLA | ADO-TRASTUZUMAB EMTANSINE | Genentech, Inc. | 23f3c1f4-0fc8-4804-a9e3-04cf25dd302e | 2026-04-01 | Boxed warning, Warnings, Adverse reactions | ADO-TRASTUZUMAB EMTANSINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.